Skip to main content
Equibles

EP Wealth Advisors, LLC

Position in ARWR — Arrowhead Pharmaceuticals, Inc.

CIK 1540569 TORRANCE, CA
Back to ARWR Full portfolio

Position in ARWR

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$3,108,383
+$700,327 QoQ
Shares Held
38,135
-0.7% QoQ
Ownership
0.027%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2022
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ARWR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

EP Wealth Advisors, LLC holds $18,108,847 across 26 Biotechnology names. ARWR ranks #2 (17.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 9,027 $4,483,981
2 ARWR
Arrowhead Pharmaceuticals, Inc.
This page 		38,135 $3,108,383
3 JAZZ
Jazz Pharmaceuticals plc
 6,385 $1,538,593
4 EXEL
Exelixis, Inc.
 23,865 $1,298,494
5 INCY
Incyte Corp
 10,863 $1,231,429
6 BNTX
BioNTech SE
 12,723 $1,183,875
7 REGN
Regeneron Pharmaceuticals, Inc.
 1,301 $811,225
8 HALO
Halozyme Therapeutics, Inc.
 8,761 $685,723

All Filings in ARWR

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,108,383 38,135
2026-03-31 $2,408,056 38,406
2025-12-31 $2,568,164 38,683
2025-06-30 $608,679 38,524
2024-06-30 $229,855 8,844
2024-03-31 $252,223 8,819
2023-12-31 $260,100 8,500
2023-09-30 $228,395 8,500
2023-06-30 $31,844 893
2023-03-31 $215,900 8,500
2022-12-31 $344,760 8,500